日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

P58 Access to clear information on infection and antimicrobial resistance: an unmet need for cancer patients at risk of, or experiencing, infection

P58 获取关于感染和抗菌素耐药性的清晰信息:癌症患者(无论其面临感染风险还是已经感染)尚未满足的需求

Chakraborty, Sajib; Chakravorty, Rajib; Alam, Saruar; Kabir, Yearul; Mahtab, Musarrat; Islam, Md Atikul; Yusuf, Md Abul Khair; Raihan, Ruksana; Al Mahtab, Mamun; Akbar, Sheikh Mohammad Fazle; Owen, Josephine; Hunt, Denise; Higgins, Gabrielle; Neugebauer, Allison; Kiely, Gillian; Riaz, Zeshan

Exploring the Replication and Pathogenic Characteristics of Alpha, Delta, and Omicron Variants of SARS-CoV-2

探索SARS-CoV-2 α、δ和ω变异株的复制和致病特性

Khan, Sakirul; Yahiro, Takaaki; Kimitsuki, Kazunori; Hashimoto, Takehiro; Matsuura, Keiko; Yano, Shinji; Noguchi, Kazuko; Sonezaki, Akane; Yoshizawa, Kaori; Kumasako, Yoko; Akbar, Sheikh Mohammad Fazle; Nishizono, Akira

Bangladesh records persistently increased number of dengue deaths in recent years: Dissecting the shortcomings and means to resolve

近年来,孟加拉国登革热死亡人数持续上升:剖析其不足之处及应对之道

Khan, Sakirul; Akbar, Sheikh Mohammad Fazle; Mahtab, Mamun Al; Yahiro, Takaaki; Hashimoto, Takehiro; Kimitsuki, Kazunori; Nishizono, Akira

Twenty-five years of Nipah outbreaks in Southeast Asia: A persistent threat to global health

东南亚尼帕病毒疫情爆发25年:对全球健康的持续威胁

Khan, Sakirul; Akbar, Sheikh Mohammad Fazle; Mahtab, Mamun Al; Uddin, Md Nasir; Rashid, Md Mamunur; Yahiro, Takaaki; Hashimoto, Takehiro; Kimitsuki, Kazunori; Nishizono, Akira

Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection

基于对慢性乙型肝炎感染发病机制生物学事件探索的治疗方法开发

Akbar, Sheikh Mohammad Fazle; Al Mahtab, Mamun; Yoshida, Osamu; Aguilar, Julio; Gerardo, Guillen Nieto; Hiasa, Yoichi

Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders

鼻内接种含HBsAg/HBcAg的疫苗可诱导乙肝疫苗无应答者产生中和性抗-HBs抗体

Shiraishi, Kana; Yoshida, Osamu; Imai, Yusuke; Akbar, Sheikh Mohammad Fazle; Sanada, Takahiro; Kohara, Michinori; Miyazaki, Takashi; Kamishita, Taizou; Miyake, Teruki; Hirooka, Masashi; Tokumoto, Yoshio; Abe, Masanori; Rubido, Julio Cesar Aguilar; Nieto, Gerardo Guillen; Hiasa, Yoichi

Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon

使用治疗性疫苗 NASVAC 或聚乙二醇干扰素治疗慢性乙型肝炎患者后,不同基因型患者的抗病毒反应

Al-Mahtab, Mamun; Akbar, Sheikh Mohammad Fazle; Yoshida, Osamu; Aguilar, Julio Cesar; Guillen, Gerardo; Hiasa, Yoichi

INASL-SAASL Consensus Statements on NAFLD Name Change to MAFLD

INASL-SAASL关于将NAFLD更名为MAFLD的共识声明

Singh, Shivaram P; Duseja, Ajay; Mahtab, Mamun Al; Anirvan, Prajna; Acharya, Subrat K; Akbar, Sheikh Mohammad Fazle; Butt, Amna S; Dassanayake, Anuradha; De, Arka; Dhakal, G P; Hamid, Saeed; Madan, Kaushal; Panigrahi, Manas K; Rao, P N; Saigal, Sanjiv; Satapathy, Sanjaya K; Shalimar; Shrestha, Ananta; Shukla, Akash; Sudhamshu, K C; Wijewantha, Hasitha

Safety profile, antiviral capacity, and liver protection of a nasal therapeutic vaccine in patients with chronic hepatitis B: Five-year-follow-up outcomes after the end of treatment

鼻腔治疗性疫苗在慢性乙型肝炎患者中的安全性、抗病毒能力和肝脏保护作用:治疗结束后五年的随访结果

Al Mahtab, Mamun; Akbar, Sheikh Mohammad Fazle; Aguilar, Julio Cesar; Yoshida, Osamu; Khan, Sakirul; Gerardo, Guillen Nieto; Hiasa, Yoichi

Impact of the Route and Schedule of Immunization on the Serological and Virological Response of Chronic Hepatitis B Patients Treated with HeberNasvac

免疫接种途径和时间安排对接受HeberNasvac治疗的慢性乙型肝炎患者血清学和病毒学反应的影响

Freyre, Freya Milagros; Aguiar, Jorge A; Cinza, Zurina; Figueroa, Nelvis; Diaz, Pablo Arsenio; Muzio, Verena Lucila; Lemos, Gilda; Freyre, Giselle; Coizeau, Edelgis; Rodríguez, Chabeli; Pentón, Eduardo; Campos, Magalys; Santos, Iván Luis; Mahtab, Mamun Al; Akbar, Sheikh Mohammad Fazle; Guillen, Gerardo E; Aguilar, Julio Cesar